Several clinical analyses have demonstrated the negative correlation of LL‐37 levels in sera with disease severity induced by SARS‐CoV‐2 [32, 33, 34], and supplementation of vitamin D (a positive regulator for CAMP) can alleviate the disease progression in COVID‐19 patients [35]. This evidence concerns the gene CAMP and COVID-19.